Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
BPREX PHARMA PACKAGING INDIA PVT. LTD. has a patent portfolio in the Medical Devices & Mechanical Engineering technology area. The company currently faces 1 pending office action. This prosecution activity involves 1 distinct examiner and a distinct art unit, which indicates a very specific focus for the company's current intellectual property efforts. The concentration in a specific art unit suggests that the technology being patented is specialized within the mechanical engineering field.
WITTLIFF, KATERINA ANNA is the busiest examiner for the company, with 1 pending office action. This matter represents the entirety of the company's current pending matters. Prosecution is concentrated, meaning the company's immediate patent goals are subject to the review of this specific examiner. Practitioners should focus on building a clear technical argument that addresses the specific concerns of this examiner. The lack of other pending actions means that the company's current strategy is entirely focused on the successful resolution of this matter. Future filings in this technology area may be influenced by the precedents set during this specific prosecution cycle.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WITTLIFF, KATERINA ANNA | 1 | 35.0% | +18.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18257942 | MEDICATION DELIVERY DEVICE | WITTLIFF, KATERINA ANNA | 44d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18257942 | MEDICATION DELIVERY DEVICE | WITTLIFF, KATERINA ANNA | 44d overdue |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18257942 | MEDICATION DELIVERY DEVICE | WITTLIFF, KATERINA ANNA | 3783 | §102§112 | Final Rejection | 44d overdue | Pending | Jun 16, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial